Discover the benefits of ASAPprime®
Stability studies are a time consuming and resource intensive task during the development of new drugs. Accelerated Stability Assessment Programme (ASAP) is an approach based on the Arrhenius equation whereby degradation increases with temperature and therefore using appropriate testing vessels and statistical analysis, it is possible to project the degradation rate at low temperature from the data generated under accelerated or stressed conditions.
Whilst the regulations require that long-term studies or real-time studies are still needed, ASAP provides an additional tool that can be applied through the whole life-cycle of the drug product, from development up to post-approval changes. Using ASAP helps to de-risk the development decision by enhancing predictive power and increasing confidence in product formulation shelf life, mitigating lifecycle risk management.
Used predominately as supportive data, ASAP can help to reduce stability commitments. Read more on ASAP here.
The team at Tepnel Pharma Services have introduced ASAPprime®, the only commercially-available software that allows for a remarkably accurate prediction of a product’s shelf-life and stability in as little as four weeks.
Read more about the Stability Testing services offered by Tepnel here.
Sign up with Tepnel today to benefit from development trials and receive a 15% discount on all subsequent clinical and registration stability studies placed at Tepnel.
Contact the team today:
Call: +44(0)1506 424 270 or Email: firstname.lastname@example.org
Meet us at Making Pharma!
Tepnel Pharma Services are exhibiting at both Making Pharmaceuticals Europe (13th-14th March 2018) and Making Pharmaceuticals UK (24th-25th April 2018). For full details visit our events page, or to arrange a meeting with one of the team contact Liz Symington or Alex McDowall today.